 
        
        
        
                货号:A457280
                
                同义名:
                    
                        
                            马替普林盐酸盐
                            
                             / Maprotiline (hydrochloride) (CRM); Maprotiline HCl
                            
                        
                    
                
                
                
                    
                     
                    
                     
                
            
Maprotiline hydrochloride是一种桥环四环抗抑郁药,具有肾上腺能活性和镇静特性,通过阻断去甲肾上腺素的再摄取,增加去甲肾上腺素在中枢神经系统中的突触浓度,进而延长去甲肾上腺素对中枢受体的作用。
 
                                 
                                
                            

| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} | {[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + | 
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
 
                        
                    
| 产品名称 | Adrenergic Receptor ↓ ↑ | α-adrenergic receptor ↓ ↑ | β-adrenergic receptor ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ivabradine HCl | ✔ | 98% | |||||||||||||||||
| Maprotiline HCl | ✔ | 98% | |||||||||||||||||
| Cisatracurium besylate | ✔ | 96% | |||||||||||||||||
| Yohimbine HCI | ✔ | 99+% | |||||||||||||||||
| BMY 7378 | ++ α2C-adrenoceptor, pKi: 6.54 α1D-adrenoceptor, pKi: 5.1 | + β1-adrenoceptor, pIC50: 5.1 | 97% | ||||||||||||||||
| Asenapine maleate | ++++ α2B-adrenergic receptor, pKi: 8.9 α2A-adrenergic receptor, pKi: 8.9 | 97% | |||||||||||||||||
| Piribedil | ++ adrenoceptor α2A, pKi: 7.1 adrenoceptor α2C, pKi: 7.2 | 98% | |||||||||||||||||
| Prazosin HCl | ✔ | 95% | |||||||||||||||||
| Silodosin | ✔ | 98% | |||||||||||||||||
| Phenoxybenzamine HCl | ✔ | 98% | |||||||||||||||||
| Labetalol HCl | ✔ | 98+% | |||||||||||||||||
| Naftopidil | +++ α1D-adrenergic receptor, Ki: 20 nM α1A-adrenergic receptor, Ki: 3.7 nM | 98% | |||||||||||||||||
| Naftopidil 2HCl | + α1-adrenergic receptor, IC50: 0.2 μM | 99% | |||||||||||||||||
| Alfuzosin HCl | ✔ | 98% | |||||||||||||||||
| Terazosin HCl | ✔ | 99% | |||||||||||||||||
| Atipamezole | ✔ | 95% | |||||||||||||||||
| Phentolamine methanesulfonate salt | ✔ | 99% | |||||||||||||||||
| Carvedilol | ✔ | 99% | |||||||||||||||||
| Doxazosin mesylate | ✔ | 99% | |||||||||||||||||
| Tolazoline HCl | ✔ | 98% | |||||||||||||||||
| Esmolol HCl | ✔ | 95% | |||||||||||||||||
| Propranolol HCl | ++ β-adrenergic receptor, IC50: 12 nM | 99% | |||||||||||||||||
| Zenidolol HCl | ++++ β1-adrenergic receptor, Ki: 611nM β2-adrenergic receptor, Ki: 0.7nM | 98% | |||||||||||||||||
| Acebutolol HCl | ✔ | 97+% | |||||||||||||||||
| Carteolol HCl | ✔ | 98+% | |||||||||||||||||
| Betaxolol | ✔ | 99% | |||||||||||||||||
| Betaxolol HCl | + β1-adrenergic receptor, IC50: 6 μM | 97% | |||||||||||||||||
| Bisoprolol | ✔ | 97% | |||||||||||||||||
| Sotalol HCl | ✔ | 95+% | |||||||||||||||||
| Nebivolol HCl | +++ β1-adrenoceptor, IC50: 0.8 nM | 99% | |||||||||||||||||
| Metoprolol | ✔ | 98+% | |||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 靶点 | 
 | 
| 描述 | Maprotiline (Hydrochloride), selective NA reuptake inhibitor, a tetracyclic antidepressant with sedative properties, exhibits strong inhibitory effects on norepinephrine uptake across nerve cell membranes but interferes relatively little with serotoninergic mechanisms[3]. Maprotiline bounds to the full-length recombinant sGC (Soluble guanylate cyclase) with a high affinity (KD = 0.307 μM). Moreover, in a monocrotaline rat model of PAH (Pulmonary arterial hypertension), maprotiline (ip, 10 mg/kg once daily) reduced pulmonary hypertension, inhibited the development of right ventricular hypertrophy and pathological changes of the pulmonary vascular remodeling[4]. | 
| Concentration | Treated Time | Description | References | |
| Vero cells | 10 or 20 μM | 4 h | Maprotiline inhibited acid sphingomyelinase activity and prevented infection with pp-VSV-SARS-CoV-2 spike particles | Cell Rep Med. 2020 Nov 17;1(8):100142 | 
| HEK293 cells | 1.51 μmol/L | Evaluate the inhibitory activity of Maprotiline on Nav1.7 channels | Acta Pharmacol Sin. 2020 Mar;41(3):293-302 | |
| HEK293T cells | 10 µM | 24 hours | Maprotiline significantly inhibited Tm/Tg-induced CHOP expression and XBP-1 splicing, indicating its restoration of ER homeostasis by inhibiting HRH1-mediated ER Ca2+ release. | Nat Commun. 2022 Nov 10;13(1):6796 | 
| Brain-stem neurons | 10^-6 M | 30 minutes | To study the effect of Maprotiline on norepinephrine uptake, results showed that Maprotiline did not affect 3H-serotonin uptake. | J Cell Biol. 1981 Oct;91(1):142-52 | 
| Rabbit isolated hearts | 8 μM | To assess the effects of Maprotiline on cardiac rhythm. Results showed that Maprotiline (8 μM) could induce dysrhythmias involving interference with atrio-ventricular synchronization. | Br J Pharmacol. 1977 Apr;59(4):651-60 | |
| Rabbit isolated hearts | 4.8 μM | 15 minutes | To evaluate the effects of Maprotiline on cardiac force and A-V contraction interval. Results showed that Maprotiline (4.8 μM) significantly reduced ventricular force but did not significantly affect atrial force or heart rate. | Br J Pharmacol. 1977 Apr;59(4):651-60 | 
| Administration | Dosage | Frequency | Description | References | ||
| Mice | Traumatic optic nerve injury model and glaucoma model | Intravitreal injection and intraperitoneal injection | 15 mg/kg | Once daily for 14 days | Maprotiline significantly protected RGC somata and axons and preserved visual functions in two mouse optic neuropathy models. | Nat Commun. 2022 Nov 10;13(1):6796 | 
| Rats | Intraperitoneal injection | 20 mg/kg and 50 mg/kg | Single injection | Maprotiline (20 mg/kg) enhanced NMDAR-EPSC, while a higher dose (50 mg/kg) reduced NMDAR-EPSC. | Biol Psychiatry. 2014 Dec 15;76(12):953-62 | |
| Mice | Huntington's disease model | In vitro culture | 2 μM | 2-3 hours pretreatment | Maprotiline, as a blocker of the mitochondrial permeability transition pore (MPTP), protects YAC128 medium spiny neurons from glutamate-induced apoptosis. | Proc Natl Acad Sci U S A. 2005 Feb 15;102(7):2602-7 | 
| New Zealand White rabbits | Conscious or barbiturate-anaesthetized rabbits | Intravenous infusion | 25 mg/kg/h | Continuous infusion until death or 5 hours | To assess the relative toxicity of Maprotiline, which showed intermediate lethal doses between amitriptyline and mianserin. In anaesthetized rabbits, it caused dose-dependent reductions in heart rate and blood pressure, ECG changes (prolonged P-R interval and widened QRS complex), and arrhythmias at higher doses than amitriptyline and imipramine but significantly lower than mianserin. | Br J Pharmacol. 1979 Feb;65(2):331-8 | 
| Rats | Anesthetized rats | Intravenous injection | 0.5 mg/kg | Single dose | To study the effect of Maprotiline on the vasodepressor responses evoked by histamine. Results showed that Maprotiline inhibited the vasodepressor responses to histamine, similar to promethazine. | Br J Pharmacol. 1981 Sep;74(1):143-8 | 
| Rats | Pithed rats | Intravenous | 0.5 mg/kg | Single administration | To compare the effects of Maprotiline with other drugs on cardiac and vascular adrenoceptors. Results showed that Maprotiline potentiated pressor responses to noradrenaline and inhibited the pressor action of tyramine. | Br J Pharmacol. 1980 Feb;68(2):321-32 | 
| NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 | 
| NCT02873234 | - | Recruiting | May 2020 | China, Beijing ... 展开 >> The Third Affiliated Hospital of Beijing University of Chinese Medicine Recruiting Beijing, Beijing, China, 100029 Contact: Wenjun Sun, MD, PHD +86 18910259376 doctorsunwenjun@126.com 收起 << | |
| NCT02374567 | Dementia Depr... 展开 >>ession Schizophrenia Psychosomatic Disorders Anxiety Disorders 收起 << | Phase 3 | Terminated | - | Germany ... 展开 >> Bezirkskrankenhaus Augsburg Augsburg, Germany Krankenhaus Hedwigshöhe Berlin, Germany Hannover Medical School Hannover, Germany, 30625 Asklepios Fachklinikum Lübben Lübben, Germany Asklepios Fachklinikum Teupitz Teupitz, Germany 收起 << | 
| NCT00704860 | Major Depression | Phase 4 | Completed | - | Canada, Ontario ... 展开 >> University of Ottawa Institute of Mental Health Research Ottawa, Ontario, Canada, K1Z 7K4 收起 << | 
| 计算器 | ||||
| 存储液制备 |  | 1mg | 5mg | 10mg | 
| 1 mM 5 mM 10 mM | 3.19mL 0.64mL 0.32mL | 15.93mL 3.19mL 1.59mL | 31.86mL 6.37mL 3.19mL | |
| CAS号 | 10347-81-6 | 
| 分子式 | C20H24ClN | 
| 分子量 | 313.86 | 
| SMILES Code | CNCCCC1(CC2)C3=CC=CC=C3C2C4=CC=CC=C14.Cl | 
| MDL No. | MFCD00079464 | 
| 别名 | 马替普林盐酸盐 ;Maprotiline (hydrochloride) (CRM); Maprotiline HCl; Ba 34276 | 
| 运输 | 蓝冰 | 
| InChI Key | NZDMFGKECODQRY-UHFFFAOYSA-N | 
| Pubchem ID | 71478 | 
| 存储条件 | In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry,2-8°C | 
| 溶解方案 | DMSO: 85 mg/mL(270.82 mM),配合低频超声,并水浴加热至45℃助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO H2O: 2 mg/mL(6.37 mM),配合低频超声助溶 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶 
 
 
 
 | 
 沪公网安备 31011702889066号
			
			沪ICP备2024050318号-1
			沪公网安备 31011702889066号
			
			沪ICP备2024050318号-1